Taurine trial in succinic semialdehyde dehydrogenase deficiency and elevated CNS GABA

Authors

Phillip L. Pearl, George Washington UniversityFollow
John M. Schreiber, George Washington UniversityFollow
William H. Theodore, George Washington University
Robert J. McCarter, George Washington University
Emily S. Barrios, Children's National Medical Center
Joe Yu, Children's National Medical Center
Edythe Wiggs, National Institutes of Health
Jianping He, National Institutes of Health
K. Michael Gibson, Washington State University,

Document Type

Journal Article

Publication Date

3-18-2014

Journal

Neurology

Volume

Volume 82, Issue 11

Inclusive Pages

940-944

Keywords

Amino Acid Metabolism, Inborn Errors--pathology; Central Nervous System--metabolism; Succinate-Semialdehyde Dehydrogenase--deficiency; Taurine--therapeutic use; gamma-Aminobutyric Acid--metabolism

Comments

PMCID: PMC3963004 [Available on 2015/3/18]

APA Citation

Pearl, P.L., Schreiber, J., Theodore, W.H., McCarter, R., Barrios, E.S. et al. (2014). Taurine trial in succinic semialdehyde dehydrogenase deficiency and elevated: CNS GABA. Neurology, 82(11), 940-944.

Peer Reviewed

1